Skip to main content
Erschienen in: Journal of Neurology 2/2014

01.02.2014 | Letter to the Editors

Responsiveness of dysphagia to acute l-Dopa challenge in progressive supranuclear palsy

verfasst von: Sara Varanese, Paolo Di Ruscio, Leila Ben M’ Barek, Astrid Thomas, Marco Onofrj

Erschienen in: Journal of Neurology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Excerpt

Dear Sirs, …
Literatur
1.
Zurück zum Zitat Litvan I, Mangone CA, McKee A, Verny R, Parsa A, Jellinger K et al (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olsewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60:615–620PubMedCentralCrossRefPubMed Litvan I, Mangone CA, McKee A, Verny R, Parsa A, Jellinger K et al (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olsewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 60:615–620PubMedCentralCrossRefPubMed
2.
Zurück zum Zitat Muller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K et al (2001) Progression of dysarthrya and dysphagia in post-mortem confirmed parkinsonian disorders. Arch Neurol 58:259–264CrossRefPubMed Muller J, Wenning GK, Verny M, McKee A, Chaudhuri KR, Jellinger K et al (2001) Progression of dysarthrya and dysphagia in post-mortem confirmed parkinsonian disorders. Arch Neurol 58:259–264CrossRefPubMed
3.
Zurück zum Zitat Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olsewzski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9CrossRefPubMed Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olsewzski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9CrossRefPubMed
4.
Zurück zum Zitat Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57–60CrossRefPubMed Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57–60CrossRefPubMed
5.
Zurück zum Zitat Ling H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135:1141–1153PubMedCentralCrossRefPubMed Ling H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135:1141–1153PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565CrossRefPubMed Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565CrossRefPubMed
7.
Zurück zum Zitat Amitrano A, Pezzella FR (2009) La valutazione della disfagia: sviluppo di una nuova scala di rischio di malnutrizione e polmonite ab ingestis. Logopedia e comunicazione N.2, pp 1–7. ISBN 978-88-6137-257-3 Amitrano A, Pezzella FR (2009) La valutazione della disfagia: sviluppo di una nuova scala di rischio di malnutrizione e polmonite ab ingestis. Logopedia e comunicazione N.2, pp 1–7. ISBN 978-88-6137-257-3
8.
Zurück zum Zitat Warnecke T, Oelenberg S, Teisman I, Hamacher C, Lohamnn H, Ringelstein EB et al (2010) Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. Mov Disord 25:1239–1245CrossRefPubMed Warnecke T, Oelenberg S, Teisman I, Hamacher C, Lohamnn H, Ringelstein EB et al (2010) Endoscopic characteristics and levodopa responsiveness of swallowing function in progressive supranuclear palsy. Mov Disord 25:1239–1245CrossRefPubMed
9.
Zurück zum Zitat Litvan I, Mangone CA, D’Olhaberriague L et al (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosci Neurosurg 60:615–620CrossRef Litvan I, Mangone CA, D’Olhaberriague L et al (1996) Natural history of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosci Neurosurg 60:615–620CrossRef
10.
Zurück zum Zitat Collins SJ, Shlskog JE, Parisi JE et al (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosci Neurosurg 58:167–173CrossRef Collins SJ, Shlskog JE, Parisi JE et al (1995) Progressive supranuclear palsy: neuropathologically based diagnostic clinical criteria. J Neurol Neurosci Neurosurg 58:167–173CrossRef
11.
Zurück zum Zitat Williams DR, de Silva R, Paviour DC, Domic C, Pittman A, Watt HC (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128:1247–1258CrossRefPubMed Williams DR, de Silva R, Paviour DC, Domic C, Pittman A, Watt HC (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128:1247–1258CrossRefPubMed
12.
Zurück zum Zitat Kompoliti K, Goetz CG, Litvan I et al (1998) Pharmacological therapy in progressive supranuclear palsy. Arch Neurol 55:1099–1102CrossRefPubMed Kompoliti K, Goetz CG, Litvan I et al (1998) Pharmacological therapy in progressive supranuclear palsy. Arch Neurol 55:1099–1102CrossRefPubMed
Metadaten
Titel
Responsiveness of dysphagia to acute l-Dopa challenge in progressive supranuclear palsy
verfasst von
Sara Varanese
Paolo Di Ruscio
Leila Ben M’ Barek
Astrid Thomas
Marco Onofrj
Publikationsdatum
01.02.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 2/2014
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7232-4

Weitere Artikel der Ausgabe 2/2014

Journal of Neurology 2/2014 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.